Skip to content

Anorectal Manometery in Pediatric Chronic Refractory Constipation

The Diagnostic Value of Anorectal Manometry in Pediatric Chronic Refractory Constipation With or Without Fecal Incontinence

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06543979
Enrollment
60
Registered
2024-08-09
Start date
2024-09-07
Completion date
2025-10-01
Last updated
2024-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Constipation

Brief summary

Anorectal manometry and high-resolution anorectal manometry (HRAM) are becoming the investigation of choice for understanding the pathophysiology of chronic constipation with or without fecal incontenance in children in many institutions. In high resolution anorectal manometery we are able to gain information whether the symptoms are related to sphincter dysfunction, impaired sensation, or pelvic floor dyssynergia

Detailed description

Primary objective: To assess different patterns of anorectal manometry in children with chronic refractory constipation with or without fecal incontinence. Secondary objective: To determine the effectiveness of different modalities of treatment of chronic refractory constipation based on the anorectal findings. To assess the safety ,tolerability and effectiveness of lubiprostone in pediatric age group with chronic refractory constipation. To assess the effect of elimination of cow milk products in patient with chronic refractory constipation.

Interventions

DRUGlubiprostone , single arm

laxative

PROCEDUREbiofeed back sessions

Biofeedback for participants with dyssynergic defecation and participants with reduced rectal sensations

Botulinum toxin injection for participants suffering from elevated anal canal pressure

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

1. Children and adolescents aged from 4 to 16 years. 2. Participants fulfilling Rome IV criteria for the diagnosis of functional constipation. At least 2 of the following present at least once per week for at least 1 month: * 2 or fewer defecations in the toilet per week * At least 1 episode of fecal incontinence per week * History of retentive posturing or excessive volitional stool retention * History of painful or hard bowel movements * Presence of a large fecal mass in the rectum * History of large-diameter stools that may obstruct the toilet The symptoms cannot be fully explained by another medical condition (Hyams et al., 2016). 3. Participants who have chronic refractory constipation. Chronic refractory constipation (CRC) is defined as children who are unable to pass stools in spite of being on maximum laxative therapy and require daily rectal stimulation in the form of enemas or suppositories to pass stools 4-Is willing and able to keep a diary on his/her own and willing and able to complete a questionnaire. 5-The participant or, when applicable, the participant's legally acceptable representative signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures.

Exclusion criteria

* participants who have anorectal malformation * participants who have neurological disease affecting lower limbs * Has a history of hypersensitivity or allergies to lubiprostone

Design outcomes

Primary

MeasureTime frameDescription
To evaluate the manometric parameters in children with chronic refractory constipation1 yearTo measure the percent of the most common manometric parameters in children with chronic refractory constipation e.g dyssengeric defecation and reduced rectal sensetivity and anal sphincter dysfunction.
evaluate the efficacy of oral administration of lubiprostone 8 and 24 μg once daily for 4 weeks in participants with chronic refractory constipation1 monthSpontaneous Bowel Movement (SBM) Frequency at Week 1,2,3 and 4 A SBM was defined as any bowel movement (BM) that does not occur within 24 hours after rescue medication use (laxative, suppository, or enema). Participants will be given a diary to complete at home where they will record all details of each SBM including the consistency of the stool and the difficulty they have in passing it.

Secondary

MeasureTime frameDescription
To determine the effect of biofeed back sessions in children with dyssengeric defecation and in children with rectal hyposensetivity3 monthsParticipants with chronic refractory constipation and manometry parameters showed dyssengeric defecation or hyposensitivity will receive biofeedback sessions and the investigators measure the difference in bowel management scoring tool before and after the biofeedback sessions the higher the score the worest the condition
To determine the effect of cow milk protein free diet on chronic refractory constipation in children1 monthParticipants will receive cow milk free diet for 4 weeks and investigators measure the difference in bowel management scoring tool before and after cow milk free diet the higher the score the worest the condition
To determine the effect of botulinum toxin injection in children with elevated anal canal resting pressure3 monthParticipants with chronic refractory and manometric parameters showed high anal canal resting pressure will have botulinum toxin injection and investigators measure the difference in bowel management scoring tool before and after the injection the higher the score the worest the condition

Countries

Egypt

Contacts

Primary Contactasmaa abdelnaby mohamed soliman, master
samka2015.abdelnaby@gmail.com+2001070689789
Backup Contactyosra mohamed mohsen awad, MD
01001831590

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026